EP’s draft position on Unitary SPC and SPC Regulation revision
by Giuliana Miglierini The Committee for Legal Affairs (JURI) of the European Parliament released the draft amendments to…
What happens after IP loss of protection
by Giuliana Miglierini What does it happen under a competitiveness perspective once intellectual property (IP) protection for medicinal…
The opportunity for repurposing of oncology medicines
by Giuliana Miglierini Rare cancers, which account for approx. 22% of new cases in Europe, represent an area…